Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2020 filings

All 53 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2020, sourced directly from the official regulator.

53 Filings
2020 Period
2020 filings (53)
Filing Released Lang
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-12-31 English
Holding(s) in Company
Major Shareholding Notification
2020-12-22 English
Investor Presentation
Investor Presentation
2020-12-21 English
Grant of share options to the CEO
Regulatory Filings
2020-12-18 English
PDMR Exercise of Share Options
Regulatory Filings
2020-12-18 English
Director/PDMR Shareholding
Director's Dealing
2020-12-14 English
Investor Presentation
Report Publication Announcement
2020-12-14 English
Second Price Monitoring Extn
Regulatory Filings
2020-12-10 English
Price Monitoring Extension
Regulatory Filings
2020-12-10 English
Update re US partnering discussions
Regulatory Filings
2020-12-10 English
Holding(s) in Company
Major Shareholding Notification
2020-11-30 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-11-30 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-11-02 English
Withdrawal of all oppositions by TEVA
Regulatory Filings
2020-10-19 English
Block Listing 6 Monthly Return
Regulatory Filings
2020-09-30 English
Total Voting Rights Update
Regulatory Filings
2020-09-30 English
Half-year Report
Interim / Quarterly Report H1 2020
2020-09-16 English
Notice of Results
Report Publication Announcement
2020-09-14 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-08-28 English
AEGIS-H2H study reanalysis
Earnings Release Q3 2020
2020-08-06 English
Total Voting Rights update
Regulatory Filings
2020-07-31 English
PT20 paper publication
Regulatory Filings
2020-07-16 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-06-30 English
Appointment of Non-Executive Director
Board/Management Information
2020-06-26 English
Results of 2020 Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements
2020-06-18 English
Feraccru®/Accrufer® publications
Regulatory Filings
2020-06-03 English
Total Voting Rights Update
Regulatory Filings
2020-05-29 English
Investor presentations
Regulatory Filings
2020-05-28 English
Appointment of Chairman
Board/Management Information
2020-05-26 English
Annual Report and Accounts 2019
Annual Report FY 2019
2020-05-22 English
2019 Annual Report and 2020 AGM Notice
Report Publication Announcement
2020-05-22 English
Second Price Monitoring Extn
Regulatory Filings
2020-05-21 English
Price Monitoring Extension
Regulatory Filings
2020-05-21 English
Preliminary Results
Earnings Release FY 2019
2020-05-21 English
Notice of Results
Regulatory Filings
2020-05-19 English
Business and trading update
Regulatory Filings
2020-05-01 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2020-04-30 English
Further re. Directorate Change
Board/Management Information
2020-04-27 English
Directorate Change
Board/Management Information
2020-04-22 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-26 English
Price Monitoring Extension
Regulatory Filings
2020-03-26 English
Holding(s) in Company
Major Shareholding Notification
2020-03-20 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-17 English
Price Monitoring Extension
Regulatory Filings
2020-03-17 English
AEGIS-H2H study update
Regulatory Filings
2020-03-17 English
Investor Presentation
Regulatory Filings
2020-03-06 English
Block Listing Application
Regulatory Filings
2020-03-02 English
Holding(s) in Company
Major Shareholding Notification
2020-02-21 English
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Regulatory Filings
2020-01-28 English
Business and trading update
Regulatory Filings
2020-01-27 English
Investor presentations
Report Publication Announcement
2020-01-24 English
Hardman & Co Research: Shield Therapeutics (STX): Taking on China
Regulatory Filings
2020-01-14 English
China licence agreement for Feraccru/Accrufer
Regulatory Filings
2020-01-08 English